Asahi Kasei Group company Zoll Medical said it inked an exclusive strategic multi-year deal with advanced manufacturing company Myant to develop technologies for future versions of Zoll’s LifeVest wearable defibrillator.
The company’s LifeVest is designed to be worn by patients at risk of sudden cardiac death to monitor the heart continuously for abnormal heart arrhythmias and responds automatically, Zoll said. The system consists of an electrode belt and chest garment and a monitor worn around the waist or with a shoulder strap.
Read the whole story on our sister site, Medical Design & Outsourcing